On CNBC's "Options Action," Mike Khouw said Moderna Inc MRNA saw more than 3 times the average daily options volume on Friday, and calls significantly outpaced puts.
The most active options were the $90-strike calls, $100-strike calls and $105-strike calls that expire on November 20. This activity suggests traders are expecting a strong vaccine-related catalyst next week and they are using options because they want to manage risk, explained Khouw.
Tony Zhang made a comparison with Pfizer Inc. PFE, which had a big move higher on the news and then it traded lower. He expects to see a similar reaction with Moderna. He wouldn't chase it because its options are very expensive.
Carter Worth likes Moderna a lot. He expects it to trade above its highs.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.